Hiring?
Logo

3D Bioprinting

location_on

North East, USA

Short Summary

* Cellular Life Sciences (CLS), a life sciences tools company with a portfolio of solutions spearheaded by 3D Bioprinting * Focused on cell-based therapies, regenerative medicine, advanced therapeutics, diagnostics development * Spinout from Digilab

Overview

Target
US$1,500,000
Minimum
US$500,000
Investment Raised
N/A
Previous Rounds N/A
Stage Achieving Sales
Investor Role Any

Highlights

  • Products currently being sold today thru Digilab (www.digilabglobal.com)
  • Very experienced management team in place
  • 3D Bioprinting market growing at 25% CAGR
  • Target rich sales environment, over 300 pharma companies identified
  • Unique ability to print 95% cells in living form, IP protected
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
20% raised

Non & Psychoactive CBD

location_on Colombia

Medical cannabis is a new industry that is growing rapidly due to its extraordinary effectiveness in the treatment of different diseases, in addition to its application in the cosmetic industry and various other industries.

US$ 5,000,000

Target

US$ 1,000,000

Min per Investor

Global Pro
0% raised

Biotech, 1st in its class

location_on South East, USA

Biotech breakthrough diagnosing pulmonary diseases. Est. market size is 329m individuals, excluding COVID-19 affected. M&A event acquiring 61% equity stake. Strategic partners - major int'l institute & US university. Projected valuation is $500m.

US$ 1,000,000

Target

US$ 10,000

Min per Investor

Pro
0% raised

AntiStress Medical Device

location_on Midwest, USA

Introducing PSONA, a stress-eliminating device that eliminates stress in an instant and brings soothing relief. Wear this device to reduce headaches, pain, anxiety, depression, etc. Call or email me to find out more

US$ 500,000

Target

US$ 50,000

Min per Investor

load one similar proposal